Marta Boffito

56 Dean Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 265 publications

Evaluation of HIV pre-exposure prophylaxis (PrEP) provision and clinical attendance patterns in London sexual health services.

Evaluation of HIV pre-exposure prophylaxis (PrEP) provision and clinical attendance patterns in London sexual health services.

Journal: Sexually transmitted infections
Published: July 14, 2026

Less frequent clinical and viral load assessments during COVID did not increase virological failure.

Less frequent clinical and viral load assessments during COVID did not increase virological failure.

Journal: International journal of STD & AIDS
Published: May 21, 2026

CROI 2026-A summary from the BHIVA CROI Working Group.

CROI 2026-A summary from the BHIVA CROI Working Group.

Journal: HIV medicine
Published: May 14, 2026

'Structured pathway for managing gastrointestinal intolerance in PrEP users: experience from a sexual health service'.

'Structured pathway for managing gastrointestinal intolerance in PrEP users: experience from a sexual health service'.

Journal: Sexually transmitted infections
Published: May 13, 2026

Prior PrEP use and discontinuation in individuals newly diagnosed with HIV.

Prior PrEP use and discontinuation in individuals newly diagnosed with HIV.

Journal: HIV medicine
Published: March 27, 2026

Therapeutic drug monitoring of letermovir in allogeneic hematopoietic cell transplant recipients: where are we?

Therapeutic drug monitoring of letermovir in allogeneic hematopoietic cell transplant recipients: where are we?

Journal: Expert opinion on drug metabolism & toxicology
Published: March 06, 2026

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026

The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.

The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.

Journal: AIDS (London, England)
Published: January 13, 2026

Uptake of rapid antiretroviral therapy following HIV diagnosis: An eight-year retrospective analysis at a UK clinic.

Uptake of rapid antiretroviral therapy following HIV diagnosis: An eight-year retrospective analysis at a UK clinic.

Journal: International journal of STD & AIDS
Published: December 22, 2025

Accelerating Generic Long-Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to Access.

Accelerating Generic Long-Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to Access.

Journal: Clinical pharmacology and therapeutics
Published: December 10, 2025

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Journal: The lancet. HIV
Published: December 09, 2025
Showing 1-12 of 265

Last Updated: 09/26/2026